2025年 新着論文 50 バイオインフォマティクス分野から論文が発表されました
Familial fibrotic hypersensitivity pneumonitis: A distinct clinical phenotype with shorter leukocyte telomere length
- PMID: 41197207
- DOI: 10.1016/j.resinv.2025.10.012
Abstract
Background: Family history is an important factor in recognizing the prognosis of interstitial lung disease (ILD), however, its significance in fibrotic hypersensitivity pneumonitis (HP), as based on the latest international guidelines, remains unclear. This study aimed to investigate the distinct clinical profile and leukocyte telomere length (LTL) of familial fibrotic HP.
Methods: We retrospectively reviewed 490 patients who underwent leukocyte telomere length (LTL) measurement, and identified 131 patients with fibrotic HP, including 19 familial cases. Chest HRCT images were reviewed using automatic deep learning-based lung analysis.
Results: Familial fibrotic HP patients were younger (age ≥60: 68.4 % vs. 91.9 %, p = 0.02) and had lower diffusing capacity for carbon monoxide (DLco) (mean [SD]: 70.9 [23.6] vs. 82.9 [23.2], p = 0.031) compared to non-familial cases. Despite similar imaging patterns and AI-based CT analysis, pathological features of usual interstitial pneumonia (UIP) were more frequent in familial cases. Age-adjusted LTL was significantly shorter in the familial group (mean [SD]: -0.26 [0.26] vs. -0.06 [0.28], p = 0.004). Furthermore, LTL correlated with serum KL-6 (r = -0.603, p = 0.006), %DLco(r = 0.629, p = 0.007), and fibrotic features according to deep learning-based CT analysis; the consolidation with traction bronchiectasis ratio (r = -0.48, p = 0.038) and the traction bronchiectasis ratio (r = -0.489, p = 0.034).
Conclusion: Familial fibrotic HP may represent a distinct clinical phenotype characterized by shorter telomeres, with LTL emerging as a potential biomarker for disease severity.
Keywords: Family history; Fibrotic hypersensitivity pneumonitis; Interstitial lung disease; Telomere length.
Copyright © 2025. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest Y.N.K. received research funding from the Ministry of Health, Labour and Welfare of Japan (JPMH20AC5001) during the past three years. The other authors have no conflicts of interest.







